Mersana Therapeutics to Present at Upcoming Investor Conferences
Mersana Therapeutics, Inc. (MRSN) will be presenting at upcoming investor conferences to discuss their pipeline of antibody-drug conjugates targeting cancers. Live webcasts and archived replays will be available on their website.
02/27/2024 - 08:01 AM
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that members of management will present at the following upcoming investor conferences:
TD Cowen 44th Annual Health Care Conference
Format: Panel discussion Date/Time: Tuesday, March 5, 2024, at 9:10 a.m. Eastern Time
Leerink Global Biopharma Conference
Format: Fireside chat Date/Time: Tuesday, March 12, 2024, at 8:40 a.m. Eastern Time
About Mersana Therapeutics www.mersana.com .
Contact: jason.fredette@mersana.com
When will Mersana Therapeutics present at the TD Cowen 44th Annual Health Care Conference?
Mersana Therapeutics will present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:10 a.m. Eastern Time.
What is the format of Mersana Therapeutics' presentation at the Leerink Global Biopharma Conference?
Mersana Therapeutics will have a fireside chat format presentation at the Leerink Global Biopharma Conference on Tuesday, March 12, 2024, at 8:40 a.m. Eastern Time.
Where can investors watch the live webcasts of Mersana Therapeutics' presentations?
Investors can watch the live webcasts of Mersana Therapeutics' presentations on the Investors & Media section of Mersana’s website at www.mersana.com.
How long will the archived replays of Mersana Therapeutics' presentations be available?
The archived replays of Mersana Therapeutics' presentations will be available for approximately 90 days following the events.
MRSN Rankings
#5398 Ranked by Stock Gains
MRSN Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Cambridge
About MRSN
mersana is rewriting the rules for immunoconjugate therapies by leveraging our fleximer platform to create precisely targeted and highly tailored drugs that radically improve patients’ lives. our fleximer platform allows us to custom design an adc with specific properties to overcome limitations of current adc approaches and increase the drug’s chances of effectively attacking a particular cancer. we engineer immunoconjugates to deliver industry-leading payloads of an array of anti-tumor agents directly to cancerous cells, controlling when, where and how those agents are released. because we can safely deliver higher quantities of therapeutic payloads directly to a tumor, mersana’s adc therapies have the potential to more effectively treat broader populations of cancer patients while significantly reducing the side effects associated with many of today’s cancer treatments.
